Nerve Repair And Regeneration Market Scope And Analysis

  • Report Code : TIPHE100001254
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 330
Buy Now

Nerve Repair & Regeneration Market Scope, Growth, Size and Share by 2028

Buy Now


Nerve Repair & Regeneration Market Report Scope

Report Attribute Details
Market size in 2021 US$ 6.61 Billion
Market Size by 2028 US$ 12.51 Billion
Global CAGR (2021 - 2028) 9.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Neurostimulation & Neuromodulation Devices
  • Biomaterials
By Application
  • Neurostimulation & Neuromodulation Applications
  • Nerve Repair & Regeneration Applications
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Axogen Corporation
  • Boston Scientific Corporation
  • Integra LifeSciences
  • Medtronic
  • Abbott Laboratories
  • Stryker Corporation
  • Neuronetics
  • LivaNova PLC
  • Baxter
  • The COVID-19 pandemic had a mixed impact on the nerve repair & regeneration market. In the first quarter of 2020, the lockdown restrictions limited the nerve injury cases, due to which there had been a reduction in the demand for biomaterials for nerve repair surgical procedures. Vehicular accidents are the most common cause of peripheral nerve injuries, but during the lockdown, nerve injuries were less owing to limited movement. However, the U.S. Department of Health & Human Services reported that in 2020, a nearly 17 percent increase was observed in deaths from accidents or unintentional injuries in the United States after the lockdown was lifted. It also reported that accidents were the 4th leading cause of death in 2020, with only 150,000 deaths below COVID-19 deaths. These deaths were observed because of the delays in the surgical procedures for accidental cases owing to the COVID-19 safety protocols. Furthermore, after the first quarter of 2020, the market saw growth at an average rate due to the rising treatment and surgical procedures for nerve injuries.

    Based on geography, the global nerve repair & regeneration market is primarily segmented into North America, Europe, Asia Pacific, Middle East and Africa (MEA), and South and Central America. The market in North America is further segmented into the US, Canada, and Mexico. The European market is subsegmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The market in Asia Pacific is subsegmented into Japan, China, India, Australia, South Korea, and the Rest of APAC. The nerve repair & regeneration market in the MEA is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA. The market in South and Central America is subsegmented into Brazil, Argentina, and the Rest of South and Central America.

    Few companies in the global nerve repair & regeneration market are Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV.